Open AccessNPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents
Author(s) -
Pedro Henrique Prata,
Cécile Bally,
Thomas Prébet,
Christian Récher,
Geoffroy Venton,
Xavier Thomas,
Emmanuel Raffoux,
Arnaud Pigneux,
Thomas Cluzeau,
Judith Desoutter,
Julie Gay,
Claude Preudhomme,
Pierre Fenaux,
Lionel Adès
Publication year - 2018
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.189886
Subject(s) - npm1 , myeloid leukemia , hypomethylating agent , medicine , azacitidine , mutation , oncology , leukemia , genetics , biology , dna methylation , gene , karyotype , chromosome , gene expression